Interleukin-37 promotes DMBA/TPA skin cancer through SIGIRR-mediated inhibition of glycolysis in CD103+DC cells.
Zeng FL, Wang XY, Hu YW, Wang Z, Li Y, Hu J, Yu JD, Zhou P, Teng X, Zhou H, Zheng HP, Zhao FL, Gu LN, Yue CC, Chen SW, Cheng J, Hao Y, Zhao QX, Zhang C, Zou S, Hu ZL, Wei XQ, Liu X, Li GL, Huang NY, Wu WL, Zhou YF, Li W, Cui K, Li J.
Zeng FL, et al. Among authors: cui k.
MedComm (2020). 2023 Mar 5;4(2):e229. doi: 10.1002/mco2.229. eCollection 2023 Apr.
MedComm (2020). 2023.
PMID: 36891351
Free PMC article.